GTP will present its CHO cell line development service during the Bioproduction of Immunotherapies Congress on 24.09.19

Published on 2019-09-11

Bioproduction of immunotherapies

The GTP team will attend the 4th edition of Bioproduction of Immunotherapies on September 24th, 2019. Don’t miss the presentation of our CSO, Hervé Ginisty, during the Innovation Session.

Bioproduction of immunotherapies – 4th edition

For this 4th edition, Mabdesign and Medicen are gathering once again to organize this one-day event dedicated to companies and laboratories having immunotherapy candidates or developing tools and services for bioproduction. More than 120 attendees and 22 exhibitors are expected in Biocitech-Romainville to discuss about "Immunotherapies: balancing Critical Quality Attributes and bioproduction yields".

Plenary sessions et innovation speeches

This edition consists of 3 plenary sessions, led by experts in the immunotherapy field, allowing to discover all the strategies to increase productivity and quality of immunotherapies in bioproduction and to learn more on quality control strategies and monitoring of bioprocesses. Hervé Ginisty, our scientific director, will speak on this topic during the Innovation Pitch session. All information about this session is available on the event program.

Meet the GTP team during B2B meetings

GTP will also be available to answer all your questions and discuss your recombinant proteins and antibodies projects, during networking breaks and B2B meetings. Don’t hesitate to contact us to schedule your meeting. Looking forward to meeting you there!